HomeReleasesTruBridge Investors Targeted in Securities Fraud I...
Releases

TruBridge Investors Targeted in Securities Fraud Investigation

TruBridge Investors Targeted in Securities Fraud Investigation

A 10.5% single-day stock price drop following a delayed annual report has triggered a formal investigation into TruBridge, Inc. The Rosen Law Firm is currently vetting potential securities claims, alleging the healthcare revenue cycle management company misled investors regarding its financial health and historical accounting practices.

The scrutiny centers on a March 17, 2026, disclosure where TruBridge admitted it could not file its annual report for the year ending December 31, 2025. Management cited the discovery of accounting errors spanning back to 2023, specifically involving revenue recognition, stock-based compensation, and capitalized software costs. These discrepancies necessitate revisions to financial statements previously filed for 2023 and 2024, as well as adjustments to multiple quarters in 2025.

Following the announcement, TruBridge shares plummeted $1.84 to close at $15.75. Shareholders who suffered losses during this period are now being sought by the Rosen Law Firm to participate in a potential class action. The firm, which operates on a contingency basis, is collecting information from affected investors via their legal portal and toll-free line to determine the scope of the recovery effort.

Share:TelegramXFacebook

Read Also

Comments (0)

Leave a comment

No comments yet. Be the first!